Pharma Journalist -

Avalon GloboCare Corp. announced a strategic partnership with the University of Natural Resources and Life Sciences (BOKU) in Vienna, Austria to develop an S-layer vaccine that can be…
Read More...

Noxopharm, a clinical-stage Australian drug development company, has announced commencement of its NOXCOVID clinical program with a planned Phase I trial in Europe. This action is…
Read More...

Zogenix, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved FINTEPLA (fenfluramine) oral solution, CIV for the treatment of seizures associated with Dravet…
Read More...

SMi reports: Registration is now open for the 4th annual Ophthalmic Drugs Conference, taking place in London on the 23rd-24th November 2020. SMi presents the 4th Annual Ophthalmic…
Read More...

Evotec SE, Samsara BioCapital, a leading life sciences investment firm, and KCK Ltd., a family investment fund, announced the launch of Autobahn Labs, a novel virtual incubator…
Read More...

Symbiosis Pharmaceutical Services, a specialist provider of pharmaceutical and vaccine development services, has announced it has signed a supply agreement with AstraZeneca for sterile…
Read More...

CSL Behring announced that it has agreed to acquire exclusive global license rights to commercialize an adeno-associated virus (AAV) gene therapy program, AMT-061 (etranacogene…
Read More...

Yumanity Therapeutics announced that it has entered into a strategic research collaboration and license agreement with Merck (known as MSD outside the United States and Canada) focused…
Read More...

NeuroRx, Inc., in partnership with RELIEF THERAPEUTICS Holding AG announced that the U.S. Food and Drug Administration (FDA) awarded Fast Track designation to NeuroRx for the…
Read More...

Replicate Bioscience, Inc. and Immunomic Therapeutics, Inc. announced that the companies have entered into a research and licensing option agreement to combine their platform…
Read More...